Does EZETIMIBE Cause Dyslipidaemia? 60 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Dyslipidaemia have been filed in association with EZETIMIBE (Ezetimibe). This represents 0.5% of all adverse event reports for EZETIMIBE.
60
Reports of Dyslipidaemia with EZETIMIBE
0.5%
of all EZETIMIBE reports
0
Deaths
18
Hospitalizations
How Dangerous Is Dyslipidaemia From EZETIMIBE?
Of the 60 reports, 18 (30.0%) required hospitalization, and 19 (31.7%) were considered life-threatening.
Is Dyslipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EZETIMIBE. However, 60 reports have been filed with the FAERS database.
What Other Side Effects Does EZETIMIBE Cause?
Myalgia (2,066)
Fatigue (876)
Drug ineffective (812)
Arthralgia (766)
Dyspnoea (766)
Nausea (742)
Dizziness (717)
Diarrhoea (688)
Headache (626)
Malaise (591)
What Other Drugs Cause Dyslipidaemia?
OLANZAPINE (230)
ROSUVASTATIN (206)
ARIPIPRAZOLE (185)
METHOTREXATE (175)
QUETIAPINE (161)
ATORVASTATIN (155)
RISPERIDONE (154)
METFORMIN (151)
TACROLIMUS (149)
ZIPRASIDONE (149)
Which EZETIMIBE Alternatives Have Lower Dyslipidaemia Risk?
EZETIMIBE vs EZETIMIBE\ROSUVASTATIN
EZETIMIBE vs EZETIMIBE\SIMVASTATIN
EZETIMIBE vs EZOGABINE
EZETIMIBE vs FACTOR XIII CONCENTRATE
EZETIMIBE vs FAM-TRASTUZUMAB DERUXTECAN-NXKI